CHONDRIAL THERAPEUTICS HOLDINGS, LLC → Larimar Therapeutics, Inc. LRMR

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 25/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (8.9 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

8 13D/G filings on this issuer

7 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 8.95

14,662,909 shares short · -4.6% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $5.57M

Point72 Asset Mgmt

Other 13D/G Filings on Larimar Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2025-07-31	SCHEDULE	Flynn James E	35.81%	30,667,474	view →
2023-03-17	SC	Flynn James E	—	—	view →
2022-09-16	SC	Flynn James E	—	—	view →
2021-07-02	SC	Flynn James E	—	—	view →
2021-05-26	SC	Flynn James E	—	—	view →
2021-05-21	SC	Flynn James E	—	—	view →
2020-07-01	SC	Flynn James E	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →